Steven Epstein

Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland.

Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ.

KBL Acquisition Corp. IV is a blank check company. It is seeking to acquire a controlling interest in a business operating in the healthcare or consumer industries in the United States. KBL Acquisition Corp. IV was founded on October 11, 2007 and is headquartered in New York, NY.

MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts.

Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom.

Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX.

Part of Welltower, Inc., Concord Health Group, Inc. is an integrated health care concern with 15 long-term care facilities with approximately 2,600 beds. The company is based in Williamsport, PA. Concord Health Group was acquired by The Multicare Cos., Inc. on February 20, 1996 for $70.70 million. The company was founded by Joseph A. Williamson.

Part of AbleSoft, Inc., Vantage Point LP publishes educational software. The company is based in Brentwood, TN. Vantage Point was acquired by AbleSoft, Inc. from Word Enterprises on November 01, 2000.

Brandywine Senior Living LLC operates a network of assisted living centers that provide care and services. Its programs include individual assessments, health monitoring, and health education, as well as assistance in coordinating care with the family and the doctor; adventure, excitement and discovery services. The company was founded in 1996 by Brenda J. Bacon, Daniel W. Lawson II and Peter J. Bruke and is headquartered in Mount Laurel, NJ.

American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX.

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

NSV II Management Co. LLC provides investment management services. It is a private equity and venture capital firm specializing in investing in growth capital, growth and expansion stage, recapitalization, mid stage, late stage, mezzanine, control buyouts, mergers and acquisitions and management buyouts in middle market companies. The company was founded by Michael A. DiPiano and Marc R. Lederman in 1999 and is headquartered in Radnor, PA.

The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA.

Carnegie Endowment for International Peace engages in the analysis and development of policy ideas and engagement and collaboration with decision makers in the government, business, and civil society. It refers to issues such as climate and energy, defense and security, democracy and governance, economy, foreign polocy, global governance, nuclear weapons, political reform, society and culture, and technology. The company was founded by Andrew Carnegie in 1910 and is headquartered in Washington, DC.

The Peres Center for Peace is a non-profit, non-political, non-governmental organization focused on developing and implementing cutting edge peacebuilding programs in innovation, peace education, medicine, business, and environment. It services include training to doctors, peace education, sports, culture and the arts and technology programs. The company was founded by Shimon Peres in 1996 and is headquartered in Tel Aviv-Jaffa, Israel.

The University of Connecticut Research & Development Corp. provides information on research and development of technologies. The company was founded in 1984 and is headquartered in Farmington, CT.

Part of XBiotech, Inc., XBiotech USA, Inc. is a company that manufactures antibodies. The company is based in Austin, TX. The company was founded in 2005. The CEO is John Simard.

Millenium Home Health Care, Inc. provides home healthcare services. It operates business through subsidiaries which include Recovery Home Care, and Angel’s Touch Home Care. The firm offers skilled nursing, physical therapy, occupational therapy, speech pathology, medical social work and home health aide services to ill or disabled older adults. It also offers personal care, at-home support services, and private duty nursing care. It also has offices in Broomall, Ft. Lauderdale, Jupiter, Milford, Philadelphia, Port St. Lucie, Sarasota, The Villages, West Pittston, and Yardley. Millenium Home Health Care was founded in 1994 and is headquartered in West Pittston, PA.

Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland.

mPharma Health Nigeria Ltd. engages in the development of a pharmaceutical data management platform. The company was founded by Gregory Rockson, Dan Shoukimas and James Finucane in 2013 and is headquartered in Accra, Ghana.

mPharma Data, Inc. engages in the development of an application that enables physicians to prescribe and locate medicines for patients. The company is headquartered in Lexington, MA.

TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then.

Jaw Capital LLC provides investment services. The private company is based in Coatesville.

National Hospice Holdings Investors LLC provides hospice services. The private company is based in Dover.

ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith.

Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation.

Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation.